Disclaimer: this research study’s copyright belongs to the authors and PubMed and not HealthMatReview.com, further details below.
Our Summary
This study focuses on the viability and function of human osteoclasts and osteoblasts having undergone PEMF exposure. Using Somagen device with extremely low frequency PEMF, results show that there was viability improvement on osteoblasts while no effects were recorded for osteoclasts. In conclusion, this supports that ELF-PEMF could be a recommended treatment for bone formation and osteoporosis.
Pubmed Study Link
PDF Study Link
Study Categories
Authors
[‘Sabrina Ehnert’, ‘Karsten Falldorf’, ‘Anne-Kristin Fentz’, ‘Patrick Ziegler’, ‘Steffen Schröter’, ‘Thomas Freude’, ‘Björn G. Ochs’, ‘Christina Stacke’, ‘Michael Ronniger’, ‘Jens Sachtleben’, ‘Andreas K. Nussler’]
PMID
28377966
PMCID
PMC5365212
Published Date
more study details
Frequency (Hz)
Frequency Range
Intensity (G)
Intensity Range
Waveform
PEMF/EMF/RF/LT
Study Subject Types
Keywords Listed
Extremely low-frequency pulsed electromagnetic fields (ELF-PEMF), Human osteoblasts, Human osteoclasts, ERK1/2, Specific EMF-responsiveness
Added Descriptive Keywords
bone, bone marrow, bone dissolution, bone regeneration, bone formation, osteoporosis, human
Disclaimer
All intellectual property and copyright of this research study sourced from PubMed, is the property of the authors and associates and is not the property of HealthMatReview.com. This research study has been included in our custom PEMF research database for the educational purposes of our readers. The on page summary, added descriptive keywords and other study details are copyright of HealthMatReview.com and were added to improve the search function of this custom research database.
Comments are moderated. Tick “Email me when my question is replied to” to get notified.